XML 49 R34.htm IDEA: XBRL DOCUMENT v3.22.0.1
Note 11 - Stockholders' Deficit (Tables)
12 Months Ended
Dec. 31, 2021
Notes Tables  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
  

2021

  

2020

 

Dividend yield

  0.0%  0.0%

Expected volatility

  86.6%  100.6%

Risk-free interest rate

  0.8%  0.9%

Expected life in years

  5.82   5.81 
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
  

For the Year Ended

 
  

December 31,

 
  

2021

  

2020

  

2019

 

Stock-based compensation:

            

Options -

            

Selling, general, and administrative

 $3,873  $3,937  $9,044 

Research and development

  573   3,018   7,452 

Restricted stock units -

            

Selling, general, and administrative

  8,239   13,841   18,848 

Research and development

  6,361   15,779   21,983 

Warrant Modification -

            

Selling, general, and administrative

  13,587   -   - 

Total stock-based compensation expense

 $32,633  $36,575  $57,327 
Share-based Payment Arrangement, Activity [Table Text Block]
  

Shares

  

Weighted Average Exercise Price

  

Weighted Average Remaining Contractual Term (years)

  

Aggregate Intrinsic Value (in thousands)

 

Outstanding at December 31, 2019

  5,042,325  $82.42   5.2  $1,951 

Granted

  700,853  $10.03   9.2  $- 

Exercised

  (18,202) $3.75      $119 

Expired

  (715,634) $90.51      $- 

Outstanding at December 31, 2020

  5,009,342  $71.42   5.1  $3,458 

Granted

  640,748  $11.12   8.2  $- 

Forfeited

  (186,339) $10.60      $- 

Expired

  (868,504) $87.55      $- 

Outstanding at December 31, 2021

  4,595,247  $62.43   4.5  $- 

Nonvested at December 31, 2021

  835,297  $10.64   8.9  $- 

Exercisable

  3,759,950  $73.93   3.6  $- 
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value [Table Text Block]
  

Shares

  

Weighted Average Grant-Date Fair Value

 

Nonvested shares at December 31, 2019

  439,194  $19.38 

Granted

  700,853  $7.81 

Vested/Issued

  (240,375) $25.57 

Nonvested shares at December 31, 2020

  899,672  $8.71 

Granted

  640,748  $7.90 

Vested/Issued

  (518,784) $9.51 

Forfeited

  (186,339) $7.96 

Nonvested shares at December 31, 2021

  835,297  $7.76 
Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]
  

Shares

  

Weighted Average Grant-Date Fair Value

 

Nonvested shares at December 31, 2019

  1,991,125  $27.63 

Granted

  1,234,616  $10.47 

Vested/Issued

  (864,881) $36.86 

Forfeited

  (506,655) $21.72 

Nonvested shares at December 31, 2020

  1,854,205  $13.51 

Granted

  1,409,733  $11.44 

Vested/Issued

  (1,089,120) $14.99 

Forfeited

  (775,501) $12.13 

Nonvested shares at December 31, 2021

  1,399,317  $11.03 
Warrant [Member]  
Notes Tables  
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]

Dividend yield

  0.0%

Expected volatility

  87.0%

Risk-free interest rate

  0.8%

Expected life in years

  5.31